FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366551203> ?p ?o ?g. }

• W4366551203 abstract "Introduction: Thalassemia is among the most common genetic disorders globally and many patients suffer from iron overload (IOL) complications that mainly affect the heart, liver and endocrine system. These events may be further complicated by drug-related problems (DRP), an inherent issue among patients with chronic diseases. Objective: The study aimed to evaluate the burden, associated factors and impacts of DRP in transfusion-dependent thalassemia (TDT) patients. Method: Eligible TDT patients under follow-up in a tertiary hospital between 01 March 2020 to 30 April 2021 were interviewed and their medical records were reviewed retrospectively to identify any DRP. DRPs were classified using the Pharmaceutical Care Network Europe (PCNE) classification version 9.1. The incidence and preventability of DRP were assessed and the associated risk factors were estimated by univariate and multivariate logistic regression. Results: A total of 200 patients were enrolled with a median (interquartile range: IQR) age of 28 years at enrolment. Approximately 1 in 2 patients were observed to suffer from thalassemia-related complications. Throughout the study period, 308 DRPs were identified among 150 (75%) participants, with a median DRP per participant of 2.0 (IQR 1.0-3.0). Of the three DRP dimensions, treatment effectiveness was the most common DRP (55.8%) followed by treatment safety (39.6%) and other DRP (4.6%). The median serum ferritin level was statistically higher in patients with DRP compared with patients without DRP (3833.02 vs. 1104.98 μg/L, p < 0.001). Three risk factors were found to be significantly associated with the presence of DRP. Patients with frequent blood transfusion, moderate to high Medication Complexity Index (MRCI) and of Malay ethnicity were associated with higher odds of having a DRP (AOR 4.09, 95% CI: 1.83, 9.15; AOR 4.50, 95% CI: 1.89, 10.75; and AOR 3.26, 95% CI: 1.43, 7.43, respectively). Conclusion: The prevalence of DRP was relatively high amongst TDT patients. Increased medication complexity, more severe form of the disease and Malay patients were more likely to experience DRP. Hence, more viable interventions targeted to these groups of patients should be undertaken to mitigate the risk of DRP and achieve better treatment outcomes." @default.
• W4366551203 created "2023-04-22" @default.
• W4366551203 creator A5015645970 @default.
• W4366551203 creator A5023335264 @default.
• W4366551203 creator A5026134980 @default.
• W4366551203 creator A5053779084 @default.
• W4366551203 creator A5058963492 @default.
• W4366551203 date "2023-04-20" @default.
• W4366551203 modified "2023-09-28" @default.
• W4366551203 title "Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study" @default.
• W4366551203 cites W1850973663 @default.
• W4366551203 cites W1909781320 @default.
• W4366551203 cites W1991405190 @default.
• W4366551203 cites W2028629918 @default.
• W4366551203 cites W2040763015 @default.
• W4366551203 cites W2045685449 @default.
• W4366551203 cites W2058969023 @default.
• W4366551203 cites W2069363844 @default.
• W4366551203 cites W2069553612 @default.
• W4366551203 cites W2085914612 @default.
• W4366551203 cites W2113847478 @default.
• W4366551203 cites W2120256142 @default.
• W4366551203 cites W2127085543 @default.
• W4366551203 cites W2134732827 @default.
• W4366551203 cites W2139561816 @default.
• W4366551203 cites W2199425450 @default.
• W4366551203 cites W2237789849 @default.
• W4366551203 cites W2320212630 @default.
• W4366551203 cites W2395206946 @default.
• W4366551203 cites W2609828520 @default.
• W4366551203 cites W2619625645 @default.
• W4366551203 cites W2763920048 @default.
• W4366551203 cites W2788938439 @default.
• W4366551203 cites W2803690438 @default.
• W4366551203 cites W2808606914 @default.
• W4366551203 cites W2890816711 @default.
• W4366551203 cites W2896656711 @default.
• W4366551203 cites W2924684276 @default.
• W4366551203 cites W2954515500 @default.
• W4366551203 cites W2991136642 @default.
• W4366551203 cites W2994874001 @default.
• W4366551203 cites W3000665604 @default.
• W4366551203 cites W3035574358 @default.
• W4366551203 cites W3038997562 @default.
• W4366551203 cites W3083542131 @default.
• W4366551203 cites W3118266342 @default.
• W4366551203 cites W3128992752 @default.
• W4366551203 cites W3135628213 @default.
• W4366551203 cites W3156362056 @default.
• W4366551203 cites W3156511137 @default.
• W4366551203 cites W3176849696 @default.
• W4366551203 cites W4206773925 @default.
• W4366551203 cites W4211214940 @default.
• W4366551203 cites W4289176108 @default.
• W4366551203 cites W4302286663 @default.
• W4366551203 doi "https://doi.org/10.3389/fphar.2023.1128887" @default.
• W4366551203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37153805" @default.
• W4366551203 hasPublicationYear "2023" @default.
• W4366551203 type Work @default.
• W4366551203 citedByCount "0" @default.
• W4366551203 crossrefType "journal-article" @default.
• W4366551203 hasAuthorship W4366551203A5015645970 @default.
• W4366551203 hasAuthorship W4366551203A5023335264 @default.
• W4366551203 hasAuthorship W4366551203A5026134980 @default.
• W4366551203 hasAuthorship W4366551203A5053779084 @default.
• W4366551203 hasAuthorship W4366551203A5058963492 @default.
• W4366551203 hasBestOaLocation W43665512031 @default.
• W4366551203 hasConcept C119060515 @default.
• W4366551203 hasConcept C120665830 @default.
• W4366551203 hasConcept C121332964 @default.
• W4366551203 hasConcept C126322002 @default.
• W4366551203 hasConcept C144301174 @default.
• W4366551203 hasConcept C156957248 @default.
• W4366551203 hasConcept C187212893 @default.
• W4366551203 hasConcept C195910791 @default.
• W4366551203 hasConcept C2777799968 @default.
• W4366551203 hasConcept C2778319317 @default.
• W4366551203 hasConcept C2780014101 @default.
• W4366551203 hasConcept C38180746 @default.
• W4366551203 hasConcept C61511704 @default.
• W4366551203 hasConcept C71924100 @default.
• W4366551203 hasConceptScore W4366551203C119060515 @default.
• W4366551203 hasConceptScore W4366551203C120665830 @default.
• W4366551203 hasConceptScore W4366551203C121332964 @default.
• W4366551203 hasConceptScore W4366551203C126322002 @default.
• W4366551203 hasConceptScore W4366551203C144301174 @default.
• W4366551203 hasConceptScore W4366551203C156957248 @default.
• W4366551203 hasConceptScore W4366551203C187212893 @default.
• W4366551203 hasConceptScore W4366551203C195910791 @default.
• W4366551203 hasConceptScore W4366551203C2777799968 @default.
• W4366551203 hasConceptScore W4366551203C2778319317 @default.
• W4366551203 hasConceptScore W4366551203C2780014101 @default.
• W4366551203 hasConceptScore W4366551203C38180746 @default.
• W4366551203 hasConceptScore W4366551203C61511704 @default.
• W4366551203 hasConceptScore W4366551203C71924100 @default.
• W4366551203 hasFunder F4320322699 @default.
• W4366551203 hasLocation W43665512031 @default.
• W4366551203 hasLocation W43665512032 @default.
• W4366551203 hasLocation W43665512033 @default.
• W4366551203 hasOpenAccess W4366551203 @default.

• next